✦ LIBER ✦

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

✍ Scribed by Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; Mathias Hänel; Marcel Reiser; Manfred Hensel; Michael Clemens; Samira Zeynalova; Marita Ziepert; Michael Pfreundschuh

Publisher: Springer
Year: 2008
Tongue: English
Weight: 259 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0500-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four versus six courses of a dose-escala

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB